Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, New York; Department of Obstetrics and Gynecology and Women's Health, Albert Einstein College of Medicine, Bronx, New York.
New York Reproductive Wellness, Jericho, New York.
Fertil Steril. 2018 Jan;109(1):165-171. doi: 10.1016/j.fertnstert.2017.10.005. Epub 2017 Nov 23.
To assess whether nucleolar channel systems (NCSs) can be detected in exfoliated endometrial epithelial cells (EECs) of uterine secretions and whether such noninvasively determined NCS status is associated with significant NCS prevalence in simultaneously obtained endometrial biopsies.
Prospective study (December 2015-February 2017).
University-affiliated and private fertility clinics.
PATIENT(S): Luteal-phase patients of reproductive age requiring endometrial biopsy for medical indications.
INTERVENTION(S): Uterine secretion aspiration before endometrial biopsy. Cells in uterine secretions were spun onto slides and fixed. NCSs were identified and quantified in cells and paraffin-embedded tissue sections by indirect immunofluorescence.
MAIN OUTCOME MEASURE(S): Comparison of NCS status of uterine secretions with NCS prevalence in biopsies. Based on NCS detection, uterine secretions were assigned a status of NCS-positive (n = 15) or NCS-negative (n = 7). NCS prevalence in biopsies was expressed as a percentage of NCSs per EECs.
RESULT(S): NCSs can be detected in exfoliated EECs of uterine secretions. Median NCS prevalence in endometrial biopsies from patients with NCS-positive secretions was 41.9% (interquartile range [IQR], 21.1-53.9) versus 2.0% (IQR, 0-6.9) when secretions were NCS-negative. The NCS status of secretions identified a significant difference in NCS prevalence of simultaneously obtained biopsies.
CONCLUSION(S): NCS status of secretions accurately reflects NCS prevalence of biopsies, a marker for the implantation window. As secretion aspiration is compatible with same-day ET, our study provides proof of principle for a minimally invasive approach to determine endometrial receptivity for timing frozen ET.
评估脱落的子宫内膜上皮细胞(EEC)的核仁通道系统(NCS)是否可以在子宫分泌物中检测到,以及这种非侵入性确定的 NCS 状态是否与同时获得的子宫内膜活检中 NCS 的高发生率相关。
前瞻性研究(2015 年 12 月至 2017 年 2 月)。
大学附属和私人生育诊所。
需要进行子宫内膜活检的生殖年龄的黄体期患者,用于医疗指征。
在子宫内膜活检前抽吸子宫分泌物。将细胞在子宫分泌物中旋转到载玻片上并固定。通过间接免疫荧光在细胞和石蜡包埋的组织切片中识别和量化 NCS。
将子宫分泌物的 NCS 状态与活检中的 NCS 发生率进行比较。根据 NCS 检测,将子宫分泌物分配为 NCS 阳性(n = 15)或 NCS 阴性(n = 7)状态。活检中的 NCS 发生率表示每 EEC 的 NCS 百分比。
可以在脱落的子宫分泌物的 EEC 中检测到 NCS。NCS 阳性分泌物患者的子宫内膜活检中 NCS 发生率的中位数为 41.9%(四分位距 [IQR],21.1-53.9),而 NCS 阴性分泌物时为 2.0%(IQR,0-6.9)。分泌物的 NCS 状态在同时获得的活检中 NCS 发生率上有显著差异。
分泌物的 NCS 状态准确反映了活检的 NCS 发生率,这是植入窗口的标志物。由于分泌抽吸与当天的 ET 兼容,我们的研究为确定冷冻 ET 的时机的子宫内膜接受能力的微创方法提供了原理证明。